PICO Portalanswers from OpenAlex

Furmonertinib for EGFR-mutant advanced non-small cell lung cancer: a glittering diamond in the rough of EGFR-TKI

PaperCitations, authors & open-access status

Furmonertinib for EGFR-mutant advanced non-small cell lung cancer: a glittering diamond in the rough of EGFR-TKI is a paper indexed in PICO Portal from OpenAlex.

How many citations does Furmonertinib for EGFR-mutant advanced non-small cell lung cancer: a glittering diamond in the rough of EGFR-TKI have?

PICO Portalcitation count

Furmonertinib for EGFR-mutant advanced non-small cell lung cancer: a glittering diamond in the rough of EGFR-TKI has 17 citations in the OpenAlex counts PICO Portal stores.

When was Furmonertinib for EGFR-mutant advanced non-small cell lung cancer: a glittering diamond in the rough of EGFR-TKI published?

PICO Portalyear

Furmonertinib for EGFR-mutant advanced non-small cell lung cancer: a glittering diamond in the rough of EGFR-TKI has 2024 year in the PICO Portal index.

Open the OpenAlex record →

What is the open-access status of Furmonertinib for EGFR-mutant advanced non-small cell lung cancer: a glittering diamond in the rough of EGFR-TKI?

PICO Portaloa status

Furmonertinib for EGFR-mutant advanced non-small cell lung cancer: a glittering diamond in the rough of EGFR-TKI has gold oa status in the PICO Portal index.

Open the OpenAlex record →

What is the DOI of Furmonertinib for EGFR-mutant advanced non-small cell lung cancer: a glittering diamond in the rough of EGFR-TKI?

PICO Portaldoi

The DOI for Furmonertinib for EGFR-mutant advanced non-small cell lung cancer: a glittering diamond in the rough of EGFR-TKI is on the source record.

Open the DOI →

What is the PMID of Furmonertinib for EGFR-mutant advanced non-small cell lung cancer: a glittering diamond in the rough of EGFR-TKI?

PICO Portalpmid

The PMID for Furmonertinib for EGFR-mutant advanced non-small cell lung cancer: a glittering diamond in the rough of EGFR-TKI is on the source record.

Open the PMID →

What is the OpenAlex record for Furmonertinib for EGFR-mutant advanced non-small cell lung cancer: a glittering diamond in the rough of EGFR-TKI?

PICO Portalopenalex

The OpenAlex for Furmonertinib for EGFR-mutant advanced non-small cell lung cancer: a glittering diamond in the rough of EGFR-TKI is on the source record.

Open the OpenAlex →